Dagyagnao, Carmen A.
HRN: 24-24-01 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/11/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/11/2023
12/17/2023
IVT
4.5g
Q6
Complicated UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes